Skip to main navigation

Jump to navigation

About
Focus
Products
- ALLN-177
- ALLN-346
- Pipeline
- FAQs
Investors
Careers
Contact

Home ›
Investors

In the News

In the News

August 10, 2018

Source

Clinical Leader

Allena Creates Oral Biologics To Treat Metabolic and Kidney Disorders

July 24, 2018

Source

BioWorld Today

News Roundup – July 24, 2018

July 23, 2018

Source

Seeking Alpha

Allena Pharma's mid-stage basket study of ALLN-177 in hyperoxaluria underway

July 23, 2018

Source

RARE Daily

Allena Doses First Patients in Mid-Stage Hyperoxaluria Trial

July 23, 2018

Source

Clinical Leader

Allena Pharmaceuticals Announces First Patients Treated In Phase 2 Basket Study Of ALLN-177 In Patients With Primary Hyperoxaluria

Pagination

First page
Previous page
Page 1
Current page 2

Investor Relations

Overview
News Releases
In the News
Events and Presentations
Stock Information
Analyst Coverage
Corporate Governance
SEC Filings
Shareholder Services

LinkedIn
LinkedIn

Privacy Policy
Terms of Use
Social Media Community Guidelines

©2019 Allena Pharmaceuticals, Inc. All rights reserved.